Athlete heart study ends early – only one person signed up
NCT ID NCT04736004
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 38 times
Summary
This study aimed to see how often COVID-19 affects the hearts of athletes. It planned to enroll college, professional, military, and Olympic athletes, with or without COVID-19, who would answer daily health surveys for 30 days and share heart images for analysis. However, the study was terminated after enrolling just one person, so it did not produce useful results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC INVOLVEMENT WITH COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University
Durham, North Carolina, 27710, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What could go wrong
The study was terminated early with only 1 participant, so no meaningful conclusions can be drawn.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.